In this episode, we dive into the lives of patients with hypertrophic cardiomyopathy (HCM) and how Aficamten is offering them hope for a better future. From breathing easier to avoiding surgery, we’ll uncover the real impact of this new treatment backed by the SEQUOIA-HCM trial. If you care about heart health or know someone living with HCM, this one’s for you.

Links to the Podcast

• Apple Podcast:⁠⁠Listen on Apple Podcast⁠⁠
• Spotify:⁠⁠Listen on Spotify⁠⁠
• Amazon Music:⁠⁠Listen on Amazon Music⁠⁠
• YouTube:⁠⁠Watch on YouTube⁠⁠

📝Source:

Study Title: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM Trial)

Publication Date: May 13, 2024

NEJM.org - SEQUOIA-HCM Trial

🔗Full Study Details:NEJM - SEQUOIA-HCM Study
🔗ClinicalTrials.gov:SEQUOIA-HCM NCT05186818

#BreathingEasier #HeartHealth #Aficamten #NewHope #SEQUOIAHCM #CardiologyTalk #Podcast #RealImpact #MedicalBreakthroughs #BetterLiving